Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2010
08/11/2010EP1499294B1 Polymerized lipids modified with peptides used as delivery system for micronutrients
08/11/2010EP1489170B1 Transporter selectively transporting sulfate conjugate and its gene
08/11/2010CN201542976U Novel black plaster with acupuncture point therapeutic function
08/11/2010CN1942179B Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
08/11/2010CN101801414A Oral and skin compositions
08/11/2010CN101801391A Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection
08/11/2010CN101801387A compositions comprising quinolone and methods for treating or controlling infections
08/11/2010CN101801372A Combinations of SAP depleting agents and anti-SAP antibodies
08/11/2010CN101801351A Solid preparation comprising alogliptin and metformin hydrochloride
08/11/2010CN101801348A tableted compositions containing atazanavir
08/11/2010CN101797386A Novel nerve protective agent
08/11/2010CN101797385A Oral calcium pharmaceutical composition
08/11/2010CN101797245A Nanoparticulate fibrate formulations
08/11/2010CN101797241A Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol
08/11/2010CN101797233A Nanoparticulate fibrate formulations
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772217 For oral administering; mixture of polyunsaturated fatty acid, phospholipids, controller of methionine metabolism such as folic acid, vitamins, minerals, zinc
08/10/2010US7772209 Antifolate combination therapies
08/10/2010US7772206 Methods and compositions for the treatment of autoimmune disorders using clofarabine
08/10/2010US7771963 Methods for determining efficacy of chemotherapeutic agents
08/10/2010US7771962 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle
08/10/2010US7771931 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/10/2010US7771930 Identifying mutation in nucleotide sequences coding immunoglobulin domain carrying polypeptide for use in diagnosis and prognosis of cell proliferative disorders
08/10/2010US7771757 For topical application and saturation of portions of sinus physiology, comprising water, zinc acetate, alkaloids; plant extract of grapefruit seed; for therapy of cold or flu
08/10/2010US7771747 Gastric acid secretion inhibiting composition
08/10/2010US7771737 Medium chain peroxycarboxylic acid compositions
08/10/2010CA2528818C Topical aerosol foams
08/10/2010CA2500886C The use of cardiac hormones for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2471745C 25-hydroxy vitamin d3 compositions
08/10/2010CA2471147C Nitric oxide donors for treatment of disease and injury
08/10/2010CA2463227C Steroidal compounds for inhibiting steroid sulphotase
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2419801C Steroid derived antibiotics
08/10/2010CA2390690C Tethered ligands and methods of use
08/10/2010CA2361617C Uses of thank, a tnf homologue that activates apoptosis
08/10/2010CA2267095C Nucleotide and protein sequence of mammastatin and methods of use
08/10/2010CA2235627C Receptor and nucleic acid molecule encoding said receptor
08/05/2010WO2010088304A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010WO2010087447A1 Finely pulverized pharmaceutical composition
08/05/2010WO2010087425A1 Prostate cancer progression inhibitor and progression inhibition method
08/05/2010WO2010087319A1 Method for screening substance useful as therapeutic agent for prostate cancer
08/05/2010WO2010087150A1 Gastric acid secretion inhibitor, and potassium channel inhibitor
08/05/2010WO2010087107A1 Melanoma metastasis inhibitor
08/05/2010WO2010086964A1 Combination therapy for treating cancer
08/05/2010WO2010086411A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients
08/05/2010WO2010086400A1 Combination treatment of breast cancer
08/05/2010WO2010086190A1 Method and device for detecting a substance applied onto a body part
08/05/2010WO2010066046A8 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
08/05/2010WO2010014784A3 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
08/05/2010WO2009052617A9 Treatment regime for proliferative disorders
08/05/2010US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
08/05/2010US20100197913 Non-nucleotide composition for inhibiting platelet aggregation
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197795 Transdermal compositions
08/05/2010US20100197719 Medicament compositions containing anticholinergically-effective compounds and betamimetics
08/05/2010US20100197701 Method of treating diabetes
08/05/2010US20100197663 Method and compositions for treatment of painful disorders
08/05/2010US20100197658 Pharmaceutical use of fused 1,2,4-triazoles
08/05/2010US20100196891 IBC-1 (Invasive Breast Cancer-1), a Putative Oncogene Amplified in Breast Cancer
08/05/2010US20100196507 Treatment of Wounds and Compositions Employed
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo
08/05/2010US20100196369 Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010CA2751236A1 Finely pulverized pharmaceutical composition
08/05/2010CA2750798A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients
08/05/2010CA2750659A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/04/2010EP2213673A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative
08/04/2010EP2213303A1 Pharmaceutical composition for treatment of cataract
08/04/2010EP2213290A1 Agent for improving motor complications or psychiatric symptoms in parkinson's disease
08/04/2010EP2213285A2 Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases
08/04/2010EP2212350A1 Therapeutic and diagnostic methods using tim-3
08/04/2010EP2212246A1 Treatment of neurological disorders
08/04/2010EP2211880A1 Treatment regime for proliferative disorders
08/04/2010EP2211863A1 Combination therapy
08/04/2010EP2211858A2 Use of quaternary pyridinium salts for inhibiting cancer metastases
08/04/2010EP2211845A2 Glucocorticoid receptor antagonists such as mifepristone for treating cushing's syndrome
08/04/2010EP2015759B1 Combination therapy
08/04/2010EP1711618B1 Methods for detecting markers associated with endometrial disease or phase
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN1882352B Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
08/04/2010CN1360502B Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders
08/04/2010CN101796039A Phenylacetic acid compound
08/04/2010CN101795685A hydroxyproline compositions and uses thereof
08/04/2010CN101795674A Tableted compositions containing atazanavir
08/04/2010CN101795664A Protective agent against damage of biological tissue caused by near-infrared ray, and product comprising the same
08/04/2010CN101792745A Expression and purification of influenza virus polymerase PA N-terminal polypeptide and crystal structure thereof
08/04/2010CN101791410A Preparation and application of conjugate of anti-infective medicament and polysaccharide and medicinal composition thereof
08/04/2010CN101791406A Use of sphingosine-1-phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases
08/04/2010CN101791397A Application of RNase III protein in staphylococcus aureus for preventing and treating staphylococcus aureus infection
08/04/2010CN101791308A Combinations comprising epothilones and pharmaceutical uses thereof
08/04/2010CN101269013B Method for preparing polymer microsphere
08/03/2010US7767787 Substance for obtaining highly effective tumor medications as well as a process
08/03/2010US7767714 Method of preventing infectious diseases
08/03/2010US7767708 Growth stimulant compositions
08/03/2010US7767702 Combinations of oxazolidinones such as rivaroxaban with a platelet aggregation inhibitor such as a clopidogrel for the prophylaxis and/or treatment of thromboembolic disorders
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767654 treating bleeding disorder selected from a chronic or acute bleeding disorder, a congenital coagulation disorder caused by a blood factor deficiency, and an acquired coagulation disorder, by administering a composition comprising a procoagulant amount of a fucoidan
1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 1151